Cargando…
Erratum to: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
Autores principales: | Ma, Brigette B. Y., Lui, Vivian W. Y., Poon, Fan Fong, Wong, S. C. Cesar, To, Ka Fai, Wong, Elaine, Chen, Honglin, Lo, Kwok Wai, Tao, Qian, Ng, Margaret Heung Ling, Cheng, Suk Hang, Chan, Anthony T. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2953628/ http://dx.doi.org/10.1007/s10637-010-9397-3 |
Ejemplares similares
-
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
por: Ma, Brigette B.Y., et al.
Publicado: (2009) -
Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinoma
por: Wong, Chi-Hang, et al.
Publicado: (2018) -
Erratum in: Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
por: Araki, Takuya, et al.
Publicado: (2013) -
Erratum to: An endoscopic modification of the simultaneous ‘above and below’ approach to large pituitary adenomas
por: Leung, Gilberto Ka Kit, et al.
Publicado: (2011) -
Erratum: A Novel, Stable, Estradiol-Stimulating, Osteogenic Yam Protein with Potential for the Treatment of Menopausal Syndrome
por: Wong, Kam Lok, et al.
Publicado: (2015)